MedTrace Logo

Drug Eluting Balloon for Treatment of Unstable Angina

NCT02760732 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-11-30

No results posted yet for this study

Summary

This study was to investigate the effect and safety of drug eluting balloon combined for treatment of unstable angina.

Conditions

  • Angina, Unstable

Interventions

DEVICE

drug eluting balloon; cutting balloon

Patients eligible for inclusion criteria were randomised to study group for percutaneous transluminal coronary angioplasty with a strategy of cutting balloon pre-dilation first and then drug eluting balloon.

DEVICE

drug eluting stent

with a strategy of drug-eluting stent implantation alone for de novo coronary artery lesions.

Sponsors & Collaborators

  • Yun Dai Chen

    lead OTHER

Principal Investigators

  • CHEN YUN DAI, MD · The General Hospital of PLA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2018-06-01
Completion
2018-08-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02760732 on ClinicalTrials.gov